Karen Ferrante

Karen Jean Ferrante is currently an Independent Director at Cogent Biosciences, Inc. since 2018, an Independent Director at MacroGenics, Inc. since 2017, and a Director at New England Women In Science Executives Club.
Former roles include Associate Director at Bristol Myers Squibb Co., Independent Director at Progenics Pharmaceuticals, Inc. from 2014 to 2020, Independent Non-Executive Director at HUTCHMED (China) Ltd. from 2017 to 2023, Independent Director at Baxalta, Inc. from 2015 to 2016, Vice President-Oncology Development at Pfizer Inc. from 1999 to 2007, Head-Oncology Therapeutic Area at Millennium Pharmaceuticals, Inc. in 2013, Chief Medical Officer at Takeda Pharmaceutical Co., Ltd. from 2007 to 2013, Chief Medical Officer and Head-Research & Technology at Tokai Pharmaceuticals, Inc. from 2014 to 2016, and Vice President-Oncology Department at Pfizer (St. Louis).
Education includes undergraduate studies at Providence College and a doctorate from Georgetown University.